Scoop has an Ethical Paywall
Licence needed for work use Learn More
 

Progen Pharmaceuticals Limited - Latest News [Page 1]

Progen Update on Phase 3 Clinical Program

Sunday, 4 November 2007, 2:32 pm | Progen Pharmaceuticals Limited

Progen Pharmaceuticals Limited (ASX: PGL; NASDAQ: PGLA) today announced that in light of the recent Fast Track designation awarded to PI-88 for the prevention of tumour recurrence following curative resection of primary liver cancer and in order to commence ... More >>

Progen Presents Data For Anti-Tumour Compounds

Wednesday, 24 October 2007, 12:28 am | Progen Pharmaceuticals Limited

Progen Presents Preclinical Data for Second-Generation Anti-Tumour Compounds at AACR-NCI-EORTC International Conference More >>

Leading CRO to Assist Trial of Progen PI-88

Thursday, 16 August 2007, 3:29 pm | Progen Pharmaceuticals Limited

Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88 - Planning for Phase 3 Trial Initiation on Track More >>

 
 
 
 
 

LATEST HEADLINES

  • PARLIAMENT
  • POLITICS
  • REGIONAL
 

Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.